Microbiome Times Magazine https://validator.w3.org/feed/docs/rss2.html BMS and Boston Medical Center Announce Research Collaboration to Investigate Markers of Immuno-Oncology Response and Resistance 5-minute Microbiome Science Roundup: December 2019 Drinking Affects Mouth Bacteria Linked to Diseases Evogene Announces Establishment of Ag-Biologicals Subsidiary – LaVie Bio Ltd. Corteva Agriscience to Invest in Evogene’s Agriculture Biologicals Subsidiary, Lavie Bio Changes in bacterial mix linked to antibiotics increase risk for type 1 diabetes ConsortiaTX Awarded Exclusive License for Food Allergy Microbial Therapy Engineered probiotic developed to treat multiple sclerosis Kanvas Biosciences Acquires Federation Bio Assets to Scale Discovery, Development and Manufacturing Leading immune-focused microbiome drug company taps Biose Industrie for manufacturing expertise From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation Breathing Engineered Bacteria: A New Approach to Treating Lung Disease Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies? Engineered gut bacteria therapy emerges as scalable potential alternative to FMT following clinical trial Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data Redefining Probiotic Manufacturing Through Advanced Nutrient Solutions Researchers Discover that Vaginal Bacteria Don’t Always Behave the Same Way EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for IBS LACTIN-V: A Promising Live Biotherapeutic for Recurrent Bacterial Vaginosis Engineered commensals for metabolic modulation of the gut-liver-brain axis Kanvas Biosciences Secures $48M Series A to advance lead immuno-oncology drug Lactic Acid’s Untapped Potential to Optimise the Vaginal Microbiota and Mucosal Environment Freya Biosciences announces positive Phase 1 data for IVF-related embryo implantation failure Opella announces strategic partnership with Verb Biotics for development of next-generation probiotic strain Women’s Health Innovation Is Not Failing – The System Around It Is Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence EnteroBiotix announces positive Phase 2 results for potential first-in-class, oral, full-spectrum microbiome therapy for IBS ‘GABA Factory’ Probiotic LP815® Improves Sleep and Reduces Stress Missing microbes in UK infant gut and probiotics highlighted by global microbiome atlas AOB Pharma receives EMA positive decision on the Pediatric Investigation Plan for development of B244 UC San Diego researchers develop new tool to predict how bacteria influence health Traces of bacteria inside brain tumors may affect tumor behavior The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies Scientists develop a way to track donor bacteria after fecal microbiota transplants Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study Concerto Biosciences Announces Positive Topline Results from Phase 1b Clinical Trial of ENS-002 in Patients with Atopic Dermatitis Ferring Presents New Data Analyses for REBYOTA® Whitepaper: Oral Drug Delivery of Live Biotherapeutics: From Development to Clinical Trial with EUDRACAP® Select Discovery of hundreds of new human gut viruses provides a new approach to studying the gut microbiome New collaborations emerge at Gut-Immune-Brain Axis (GIBA) Network+ launch event Phagos Raises €25m Series A New strains of beneficial gut bacteria discovered in animals CRISPR study reveals surprising role of Cas9 as a guardian of bacterial defence Study finds significant health benefits in adolescents with obesity treated with FMT Persephone Biosciences Unveils First-Of-Its-Kind Synbiotic Designed To Restore Critical Gut Microbes In Babies MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline New study explores effects of fungicide use on corn health and microbiome Towards a diagnostic test: the gut microbiome as a clinical target for screening for colorectal cancer Home